STOCK TITAN

SIRIUSPOINT LTD WT 26 Form 4 Filings

SSPFF OTC

Every Form 4 that SIRIUSPOINT LTD WT 26 (SSPFF) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow SSPFF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SSPFF filings page.

Rhea-AI Summary

SiriusPoint Ltd Chief Financial Officer James J. McKinney reported a routine tax-related share disposition. On May 31, 2026, 3,648 Common Shares were withheld at $21.35 per share to cover current tax liabilities tied to vesting of restricted share units. This was not an open-market sale. After the withholding, McKinney directly holds 50,711 Common Shares, which the disclosure notes includes restricted shares.

Rhea-AI Summary

Robart Jason reported acquisition or exercise transactions in this Form 4 filing.

SiriusPoint Ltd director Jason Robart reported an equity grant of 5,903 Common Shares at $23.29 per share. This is a compensation-related award, not an open-market purchase. Following the grant, he holds 97,303 Common Shares directly.

The holding total includes restricted shares that are scheduled to vest in full on May 30, 2027, subject to his continued service as a director. This filing reflects routine director compensation and does not indicate discretionary buying or selling in the market.

Rhea-AI Summary

Mahmud Mehdi reported acquisition or exercise transactions in this Form 4 filing.

SiriusPoint Ltd director Mahmud Mehdi received a grant of 5,903 Common Shares at a reference price of $23.29 per share. This award increases his direct holdings to 123,558 Common Shares.

The position includes restricted shares scheduled to vest in full on May 30, 2027, conditional on his continued service as a director.

Rhea-AI Summary

Masojada Bronislaw Edmund reported acquisition or exercise transactions in this Form 4 filing.

SiriusPoint Ltd director Bronislaw Edmund Masojada received an equity award of 5,903 Common Shares, valued at $23.29 per share. This was a grant, not an open-market purchase, and increased his direct holdings to 65,727 Common Shares. The position includes restricted shares that vest in full on May 30, 2027, subject to his continued service as a director.

Rhea-AI Summary

Ludlow Sharon M reported acquisition or exercise transactions in this Form 4 filing.

SiriusPoint Ltd director Sharon M. Ludlow reported receiving a grant of 5,903 Common Shares of the company on May 29, 2026, recorded at $23.29 per share. This is a compensation-related award, not an open‑market purchase.

After this grant, Ludlow directly holds 160,693 Common Shares, which include restricted shares. The footnotes state that some of these restricted shares will vest in full on May 30, 2027, if she continues to serve as a director through that date.

Rhea-AI Summary

Hudson Martin Peter reported acquisition or exercise transactions in this Form 4 filing.

SiriusPoint Ltd director Hudson Martin Peter received an equity award of 5,903 Common Shares at $23.29 per share. This grant increases his direct holdings to 9,601 Common Shares. The total includes restricted shares scheduled to vest in full on May 30, 2027, contingent on his continued service as a director.

Rhea-AI Summary

SiriusPoint Ltd director Susan Lee Cross reported an equity award of 5,903 Common Shares on May 29, 2026. The shares were valued at $23.29 per share at grant and represent a compensation-related acquisition, not an open-market purchase.

After this grant, Cross directly holds 23,887 Common Shares, which include restricted shares. A portion of these restricted shares will vest in full on May 30, 2027, subject to her continued service as a director.

Rhea-AI Summary

Purtill Sabra R. reported acquisition or exercise transactions in this Form 4 filing.

SiriusPoint Ltd director Sabra R. Purtill received a grant of 5,903 common shares as equity compensation. The shares are restricted and vest in full on May 30, 2027, subject to her continued service as a director. Following this award, she directly holds 5,903 common shares.

Rhea-AI Summary

SiriusPoint Ltd Chief Executive Officer Scott Egan reported internal share transfers with no market trade. On May 11, 2026, a total of 33,164 Common Shares moved between his direct holdings and Egan Family Investment Ltd., a UK family investment company, for estate planning purposes, with no consideration paid. Following these restructuring transactions, Egan holds 1,336,694 Common Shares indirectly through Egan Family Investment Ltd., which includes restricted shares, and 117,213 Common Shares directly. These are classified as "other" transactions rather than open‑market buys or sells.

Rhea-AI Summary

SiriusPoint Ltd reported that Group Chief Underwriting Officer Anthony Shapella had 911 common shares withheld on April 30, 2026 to cover current tax liabilities tied to vesting restricted share units. This was a tax-withholding disposition, not an open-market sale. After this event, Shapella directly owned 43,942 common shares, including restricted shares.

Rhea-AI Summary

SiriusPoint Ltd executive Robin Gibbs, CEO of SiriusPoint International, reported a routine tax-related share disposition. On the vesting of restricted share units, 2,174 Common Shares were withheld at $23.29 per share to cover current tax liabilities. Following this withholding, Gibbs directly owns 164,063 Common Shares, which includes restricted shares.

Rhea-AI Summary

SiriusPoint Ltd executive Leonardo Thomas C., Global Head of A&H, had 2,413 Common Shares withheld at $23.29 per share to cover tax liabilities related to vesting restricted share units. After this tax-withholding disposition, he holds 250,697 Common Shares, which the filing notes include restricted shares.

Rhea-AI Summary

SiriusPoint Ltd executive Charles Patrick John, Global Head of P&C, reported a tax-related share disposition. On the vesting of restricted share units, 1,068 Common Shares were withheld at $23.29 per share to cover current tax liabilities. Following this non-market tax-withholding event, he holds 145,658 Common Shares directly, which includes restricted shares.

Rhea-AI Summary

SiriusPoint Ltd Group President David E. Govrin reported a tax-related share withholding. On the vesting of restricted share units, 4,488 Common Shares were withheld on April 30, 2026 at $23.29 per share to cover current tax liabilities.

After this tax-withholding disposition, Govrin directly owns 673,208 Common Shares, which the disclosure notes include restricted shares. This event reflects routine tax settlement on equity compensation rather than an open-market trade.

Rhea-AI Summary

SiriusPoint Ltd Chief Financial Officer James J. McKinney reported a tax-related share disposition. On the vesting of restricted share units, 2,620 common shares were withheld at $23.29 per share to cover current tax liabilities. Following this withholding, he directly owns 54,359 common shares, which include restricted shares.

Rhea-AI Summary

SiriusPoint Ltd director and CEO Scott Egan reported routine share updates, mainly related to tax withholding and existing holdings. On April 30, 2026, 4,247 Common Shares were withheld at $23.29 per share to cover current tax liabilities on vesting restricted share units, a non-market transaction.

After this tax-withholding disposition, Egan held 133,795 Common Shares directly, which include restricted shares. He also had 1,320,112 Common Shares held indirectly through Egan Family Investment Ltd. This filing reflects compensation-related and ownership-structure details rather than open-market buying or selling.

Rhea-AI Summary

Egan Scott reported acquisition or exercise transactions in this Form 4 filing.

SiriusPoint Ltd Chief Executive Officer Scott Egan reported routine equity compensation and an internal ownership restructuring. He received 48,625 Restricted Share Units granted under the SiriusPoint Ltd 2023 Omnibus Incentive Plan, which will vest in equal annual installments over three years based on continued employment.

On the same date, 775,029 common shares were transferred from his direct ownership to indirect ownership through Egan Family Investment Ltd., a UK family investment company, for estate planning purposes, with no consideration paid. After these transactions, Egan holds 138,042 common shares directly, and 1,320,112 common shares indirectly through Egan Family Investment Ltd.

Rhea-AI Summary

Charles Patrick John reported acquisition or exercise transactions in this Form 4 filing.

SiriusPoint Ltd granted Global Head of P&C Charles Patrick John 10,717 common shares as a share-based award, recorded at a price of $0.00 per share, indicating compensation rather than a market purchase. The award includes 10,717 Restricted Share Units granted under the SiriusPoint Ltd 2023 Omnibus Incentive Plan, which will vest in equal annual installments over three years based on continued employment. After this grant, John directly holds 146,726 common shares, including restricted shares and RSUs.

Rhea-AI Summary

Govrin David E. reported acquisition or exercise transactions in this Form 4 filing.

SiriusPoint Ltd Group President David E. Govrin received an equity award of 19,926 Common Shares on April 28, 2026, as a grant under the company’s 2023 Omnibus Incentive Plan. The award consists of Restricted Share Units that vest in equal annual installments over three years based on continued employment. Following this grant, Govrin directly holds a total of 677,696 Common Shares, which includes restricted shares and the newly granted RSUs.

Rhea-AI Summary

SiriusPoint Ltd Chief Financial Officer James J. McKinney received a grant of 15,180 Common Shares on April 28, 2026, reported as a grant or award acquisition. The shares were granted at a price of $0.00 per share as part of his compensation.

The grant includes 15,180 Restricted Share Units under the SiriusPoint Ltd 2023 Omnibus Incentive Plan, which will vest in equal annual installments over three years based on continued employment. After this award, McKinney directly holds a total of 56,979 Common Shares, including RSUs and restricted shares.

Rhea-AI Summary

SiriusPoint Ltd reported that Global Head of A&H Leonardo Thomas C. acquired additional equity through a compensation-related award. He received 12,746 Restricted Share Units (RSUs) of Common Shares at no cash cost, granted under the SiriusPoint Ltd. 2023 Omnibus Incentive Plan.

The RSUs will vest in equal annual installments over three years, conditioned on continued employment. Following this award, Thomas directly holds 253,110 Common Shares, which include the newly granted RSUs and other restricted shares.

Rhea-AI Summary

Gibbs Robin reported acquisition or exercise transactions in this Form 4 filing.

SiriusPoint Ltd reported that Robin Gibbs, CEO of SiriusPoint International, received a grant of 10,766 Common Shares in the form of Restricted Share Units at a price of $0.00 per share. These RSUs were granted under the SiriusPoint Ltd. 2023 Omnibus Incentive Plan and will vest in equal annual installments over three years based on continued employment. After this award, Gibbs directly holds 166,237 Common Shares, which include restricted shares and the newly granted RSUs.

Rhea-AI Summary

Shapella Anthony reported acquisition or exercise transactions in this Form 4 filing.

SiriusPoint Ltd granted Group Chief Underwriting Officer Anthony Shapella an equity award tied to company common shares. The award includes 5,895 Restricted Share Units (RSUs) granted under the SiriusPoint Ltd. 2023 Omnibus Incentive Plan at no cash cost to him.

The RSUs will vest in equal annual installments over three years, contingent on continued employment, aligning part of his compensation with the company’s long-term performance. Following this grant, Shapella beneficially owns 44,853 common shares, including restricted shares.

Rhea-AI Summary

SiriusPoint Ltd executive Leonardo Thomas C., Global Head of A&H, reported several routine share dispositions tied to equity compensation. On April 14, 2026, a total of 78,454 Common Shares were withheld at $22.67 per share to cover tax liabilities on vesting of performance-based and other restricted share units. After these tax-withholding transactions, he directly holds 240,364 Common Shares, which include restricted shares.

Rhea-AI Summary

SiriusPoint Ltd executive Leonardo Thomas C., Global Head of A&H, reported routine equity compensation and related tax transactions. He received a grant of 15,622 Restricted Share Units under the 2023 Omnibus Incentive Plan, which vest in equal annual instalments over three years based on continued employment. Across several dates, a total of 24,450 common shares were withheld to cover current tax liabilities tied to vesting restricted share units, at prices between $16.04 and $18.72 per share. These are compensation-related awards and tax-withholding dispositions rather than open-market trades.

Rhea-AI Summary

SiriusPoint Ltd executive Robin Gibbs, CEO of SiriusPoint International, reported routine tax-related share dispositions rather than open-market sales. On April 14, 2026, a total of 79,115 common shares were withheld at $22.67 per share to cover current tax liabilities tied to the vesting of performance-based restricted share units and restricted share units. Following these tax-withholding events, Gibbs directly holds 155,471 common shares, which include restricted shares.

Rhea-AI Summary

Govrin David E. reported acquisition or exercise transactions in this Form 4 filing.

SiriusPoint Ltd Group President David E. Govrin reported an equity award of 315,738 common shares at a stated price of $0.0000 per share. A footnote explains this represents 315,738 Performance Restricted Share Units achieved at 200% of target from a 2023–2025 grant under the SiriusPoint Ltd. 2023 Omnibus Incentive Plan, scheduled to vest on April 14, 2026. Following this award, Govrin directly holds 833,713 common shares, which the disclosure notes includes restricted shares.

Rhea-AI Summary

SiriusPoint Ltd Group Chief Underwriting Officer Anthony Shapella reported a tax-related share disposition. On February 27, 2026, 2,248 common shares were withheld to cover current tax liabilities tied to the vesting of restricted shares. Following this, he directly owns 39,967 common shares, including restricted shares.

Rhea-AI Summary

SiriusPoint Ltd reported that Chief Executive Officer Scott Egan acquired 776,096 common shares on February 26, 2026 through a grant/award at a price of $0.00 per share. This reflects performance-based equity compensation rather than an open-market purchase.

A footnote explains the award represents performance restricted share units from a 2023–2025 grant that achieved 200% of target and will vest on April 14, 2026. After this award, Egan directly holds 1,015,179 common shares, and separately reports indirect ownership of 545,083 shares held through Egan Family Investment Ltd.

Rhea-AI Summary

SiriusPoint Ltd executive Robin Gibbs, CEO of SiriusPoint International, reported an acquisition of 153,988 common shares on a no-cash basis. These shares represent Performance Restricted Share Units earned at 200% of target under a 2023–2025 grant. Following this award, Gibbs holds 234,586 common shares in total, which the company notes include restricted shares. The performance share units are scheduled to vest on April 14, 2026.

Rhea-AI Summary

SiriusPoint Ltd’s chief executive officer and director Scott Egan reported an internal transfer of 545,083 common shares of SiriusPoint on 12/19/2025. The shares moved from his direct ownership to indirect ownership through Egan Family Investment Ltd., a UK family investment company, for estate planning purposes, and the filing states that no consideration was paid for the transfer.

After the transactions, Egan directly owns 239,083 common shares, and indirectly owns 545,083 common shares through Egan Family Investment Ltd. The filing notes that these holdings include restricted shares.

Rhea-AI Summary

SiriusPoint Ltd. executive David E. Govrin, Group President, reported a share transaction involving company common shares. On 11/30/2025, 52,800 common shares were withheld at a price of $0 under transaction code "F", which indicates shares were withheld to cover current tax liabilities tied to the vesting of restricted shares. Following this transaction, he beneficially owned 517,975 common shares, which include restricted shares. The reported holdings were also adjusted to correct a prior overstatement by 6,570 shares.

Rhea-AI Summary

SiriusPoint Ltd. reported an insider equity transaction by its Group Chief Underwriting Officer, Anthony Shapella. On 11/30/2025, 2,375 common shares were withheld with a transaction code "F," which indicates shares were surrendered to cover current tax liabilities related to the vesting of restricted shares. The price is shown as $0 because this is a tax withholding event rather than an open-market sale or purchase.

After this transaction, Shapella beneficially owned 42,215 common shares, which the disclosure notes include restricted shares. This type of activity is administrative in nature and reflects routine handling of taxes when equity awards vest.